The SFRP4 gene helps control signals that guide bone growth and the balance between building and reshaping bone. This gene plays an important role in keeping long bones properly shaped and their outer layer strong. If both copies do not work, a person can develop Pyle disease, a rare inherited condition with widened bones, knock knees, and bone changes seen on X-rays. Researchers also study the SFRP4 gene for its wider effects on bone health.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly help direct when certain processes happen, where they happen, and how strongly they are carried out. As a group, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a more in depth look at this topic, you can find more in the LearnHub.
Overview
SFRP4Gene function
What if the gene works
The SFRP4 gene helps control signals between cells that guide bone growth and normal tissue repair. Its protein fine tunes Wnt signaling (a cell communication system) important for development and tissue balance.
Risk
What if the gene does not work
More severe variants in the SFRP4 gene can cause Pyle disease, a condition affecting bone growth. People may have widened long bones, knock knees, or fractures, with features ranging from mild to more noticeable.
Treatment
What does that mean for your treatment
No treatment or management approach specific to the SFRP4 gene is currently established for people with pathogenic variants in the SFRP4 gene. The SFRP4 gene is being studied in WNT signaling research as a possible biomarker or drug target in bone and cancer biology.
Conditions associated with SFRP4
Gene function
What if the gene works
Your cells need clear signals to know when to grow, mature, or stay quiet. The SFRP4 gene helps manage some of these messages outside the cell by shaping WNT signaling, a communication system used across the body. This supports organized development and routine tissue maintenance.
The SFRP4 gene makes a protein that is released outside cells, where it adjusts WNT signals between nearby cells. When these messages stay balanced, cells can respond in a more controlled, orderly way.
By shaping WNT signaling, the SFRP4 gene helps cells decide when to grow, settle into a specific job, or hold back. This is an important part of how the SFRP4 gene works in the body during normal growth and everyday tissue upkeep.
Many tissues use WNT messages to renew themselves and keep their structure organized. The SFRP4 protein helps fine tune those outside signals so cell activity stays coordinated over time.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the SFRP4 gene can weaken or remove the SFRP4 protein, often by truncating it, destabilizing it, or reducing how well it is secreted outside the cell. Many variants in the SFRP4 gene linked to Pyle disease cause loss of function, so the protein cannot restrain WNT signaling, a cell messaging pathway involved in bone remodeling. Milder variants may leave some activity, while more severe variants can abolish it, which may influence how early bone changes appear and how marked they become.
How variants are linked to conditions
Pathogenic variants in the SFRP4 gene cause Pyle disease, a rare inherited condition affecting bone growth and bone strength. In SFRP4-related Pyle disease, people may have widened bones near the joints, knock knees, differences in limb shape, short stature, dental changes, or fractures, although the pattern can vary. Finding disease-causing variants in both copies of the SFRP4 gene can confirm this diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common throughout the general population. Most do not directly affect health and simply contribute to natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to SFRP4. For the rare bone condition linked to harmful changes in this gene, risk is mainly set by the genetic change itself rather than lifestyle, and anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of SFRP4 variants
SFRP4-related Pyle disease follows an autosomal recessive inheritance pattern. This means a child inherits one altered copy of the SFRP4 gene from each parent, and parents are usually healthy carriers. When both parents carry an SFRP4 variant, each pregnancy has a 25% chance of an affected child, a 50% chance of a child who is also a carrier, and a 25% chance of a child with two working copies. In practical terms, SFRP4 gene inheritance for this condition depends on both parents passing on the changed gene copy.
What does my SFRP4 result mean for my family?
For families affected by SFRP4-related Pyle disease, close relatives may also carry the gene change. Brothers and sisters may be affected or may be healthy carriers, and parents are often carriers without symptoms. Children of someone with Pyle disease will usually carry one changed copy, and the chance of having an affected child depends on whether the other parent also carries an SFRP4 change.
Genetic information
Genetic testing
How you find out about variants
To find out about variants in the SFRP4 gene, doctors use SFRP4 genetic testing on a blood or saliva sample. A lab reads the gene’s DNA code and looks for changes, then reports whether a variant is likely benign, uncertain, or linked to disease. This can help confirm whether SFRP4 variants are present.
When should I consider getting a genetic test?
Genetic testing for the SFRP4 gene may be worth considering when someone has signs of Pyle disease, a rare condition affecting bone growth, such as knock knees, unusually wide bones near the knees, or a family history of the condition. It can also help clarify the cause when these bone changes show up on X-rays.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies by the condition and by the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. In some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when considered with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same treatment may work well for one person, work less well for another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics studies how differences in genes affect the response to medications. It examines links between genes and drugs to help explain why the same treatment can work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the SFRP4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
The SFRP4 gene entered medical research in the 1990s, when scientists identified a group of genes related to Frizzled proteins and named them secreted frizzled related proteins. In recent decades, awareness of this gene’s role has grown. Early work placed the SFRP4 gene within the wider study of Wnt signaling, an area that reshaped how researchers think about growth, tissue development, and cancer biology. A major step came later when variants in the SFRP4 gene were linked to Pyle disease, a rare inherited condition affecting bone shape and strength. From these first observations, research expanded steadily, and SFRP4 became part of the broader story of how gene discoveries can connect basic laboratory science with rare bone conditions.